0
Skip to Content
About
PNOC Foundation
Leadership Team
Impact Report
A history making FDA drug approval
Clinical trial spotlight: high-grade glioma
ONC201's FDA drug approval for Diffuse Midline Glioma
Press Release : Lose No Child Campaign Launch
News, Press Releases, Scientific Publications
Patient Families
Patient Family Resources
PNOC Participating Hospitals
Ways to Help
Events
Many Races One Fight
Gratitude Gala
Ways to Give
Donor-Advised Funds
Donate Stock
Donate with Crypto
Matching Gifts
Fundraise for cures
Memorial & Tribute Gifts
Plan Your Legacy
Lose No Child Campaign
Donate now
Open Menu
Close Menu
About
PNOC Foundation
Leadership Team
Impact Report
A history making FDA drug approval
Clinical trial spotlight: high-grade glioma
ONC201's FDA drug approval for Diffuse Midline Glioma
Press Release : Lose No Child Campaign Launch
News, Press Releases, Scientific Publications
Patient Families
Patient Family Resources
PNOC Participating Hospitals
Ways to Help
Events
Many Races One Fight
Gratitude Gala
Ways to Give
Donor-Advised Funds
Donate Stock
Donate with Crypto
Matching Gifts
Fundraise for cures
Memorial & Tribute Gifts
Plan Your Legacy
Lose No Child Campaign
Donate now
Open Menu
Close Menu
Folder:
About
Back
PNOC Foundation
Leadership Team
Impact Report
A history making FDA drug approval
Clinical trial spotlight: high-grade glioma
ONC201's FDA drug approval for Diffuse Midline Glioma
Press Release : Lose No Child Campaign Launch
News, Press Releases, Scientific Publications
Folder:
Patient Families
Back
Patient Family Resources
PNOC Participating Hospitals
Folder:
Ways to Help
Back
Events
Many Races One Fight
Gratitude Gala
Ways to Give
Donor-Advised Funds
Donate Stock
Donate with Crypto
Matching Gifts
Fundraise for cures
Memorial & Tribute Gifts
Plan Your Legacy
Lose No Child Campaign
Donate now
Back to All Events
PNOC Scientific Briefing
Monday, May 19, 2025
8:00 AM
9:00 AM
Google Calendar
ICS
Previous
Previous
May 13
PNOC DIPG Informational Webinar
Next
Next
June 25
A GLOBAL EFFORT TO CURE PEDIATRIC BRAIN CANCER, ROOTED IN SAN FRANCISCO
